Stay updated on CANDOR Clinical Trial
Sign up to get notified when there's something new on the CANDOR Clinical Trial page.

Latest updates to the CANDOR Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study locations were expanded with new site entries across the US (Florida, Georgia, Illinois, Indiana, Mississippi, New Jersey, New York, North Carolina, Ohio, South Carolina, Texas), Australia (New South Wales, Queensland, South Australia, Victoria), Canada (Alberta, Ontario, Quebec), Japan (Aichi-ken, Chiba, Fukuoka, Gifu, Gunma, Kyoto, Niigata, Okayama-ken, Osaka, Saitama, Tochigi, Tokushima, Tokyo), and Spain (Castilla León, Cataluña, Navarre); several previously listed locations were removed in this revision (v3.3.3).SummaryDifference2%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no user-facing content or study details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated to v3.3.1, and the previous revision v3.2.0 was removed.SummaryDifference0.0%

- Check45 days agoChange DetectedThe funding-status notice on the page was removed, and the core study information remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots. The page content remains consistent with the study details for NCT03158688.SummaryDifference0.2%

- Check88 days agoChange DetectedUpdated disease terminology to be current (Multiple myeloma) and bumped revision to v3.2.0; removed older term Plasma cell myeloma and older version v3.0.2; added a government-operating-status notice.SummaryDifference1%

Stay in the know with updates to CANDOR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CANDOR Clinical Trial page.